Saturday, 31 October 2026European Markets

Carrefour, Carmila, and JCDecaux launch retail media network across 179 Spanish locations in 2027

Four major retail and advertising players are expanding their retail media partnership to Spain, deploying digital screens across 91 shopping centres and 88 mall access points starting January 2027. The collaboration between Carrefour, Carmila, Unlimitail, and JCDecaux marks a significant consolidation in Europe's retail advertising market.

Carrefour, Carmila, and JCDecaux launch retail media network across 179 Spanish locations in 2027
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Carrefour, Carmila, Unlimitail, and JCDecaux will roll out a retail media network across 179 Spanish locations from January 2027, extending their French partnership into the Iberian market.

The network will deploy indoor digital out-of-home (DOOH) screens across 91 shopping centres operated by Carmila. An additional 88 outdoor locations—covering access areas to malls and Carrefour hypermarkets—will feature both traditional out-of-home (OOH) and DOOH advertising inventory.

JCDecaux, Europe's largest outdoor advertising company, brings media planning and sales expertise to the partnership. Unlimitail, Carrefour's retail media arm, contributes customer data and targeting capabilities. Carmila, the shopping centre subsidiary majority-owned by Carrefour, provides the physical infrastructure.

The Spain expansion follows the same partnership model launched in France. Retail media networks combine physical advertising space with retailer customer data to offer brands targeted campaigns at point-of-purchase locations.

Europe's retail media market is consolidating as grocers and shopping centre operators seek new revenue streams beyond traditional store rent and product sales. Retailers control valuable shopper data and high-traffic locations, making them attractive partners for advertising companies.

Spain represents a strategic growth market for retail media. The country hosts 575 shopping centres with annual visitor traffic exceeding 2.4 billion, according to Spanish shopping centre association data. Carrefour operates 187 stores across Spain, giving the partnership immediate scale.

The partnership structure splits responsibilities: JCDecaux manages advertising sales and screen operations, Carmila provides locations and manages landlord relationships, Unlimitail supplies data infrastructure, and Carrefour offers store access and brand alignment.

Digital screens enable dynamic pricing and real-time campaign adjustments—capabilities traditional static posters cannot match. Advertisers can test creative variations and measure foot traffic impact through mobile location data integrations.

The 2027 launch timeline suggests installation work will begin in late 2026. Neither the investment size nor revenue-sharing terms were disclosed in the announcement.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]Press releaseGlobeNewswire· December 9, 2025
    Carrefour, Carmila, Unlimitail and JCDecaux join forces to accelerate the development of retail media across Carrefour and Carmila sites in France and Spain
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com